Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare Q4 revenue rises 7.0% to $296.5 million; fiscal 2026 EPS outlook $4.70 to $4.82

Positive Impact 3 of 5 earnings Written later

Prestige Consumer Healthcare reported higher fourth-quarter and full-year fiscal 2025 revenue and diluted earnings per share versus the prior year, and gave initial fiscal 2026 guidance of $1,140 million to $1,155 million in revenue and $4.70 to $4.82 in diluted EPS. The company also recorded a $12.5 million non-cash tradename impairment in the quarter, which it said relates to non-strategic brands, and cited an expected approximately $15 million tariff-related headwind for fiscal 2026.

Key points

  • Q4 fiscal 2025 revenue of $296.5 million rose 7.0% from $277.0 million; diluted EPS was $1.00 versus $0.98
  • Fiscal 2025 revenue of $1,137.8 million rose 1.1%; diluted EPS was $4.29 versus $4.17, and adjusted diluted EPS was $4.52 versus $4.21
  • Fiscal 2026 outlook: revenue of $1,140 million to $1,155 million, diluted EPS of $4.70 to $4.82, and free cash flow of $245 million or more
  • Q4 included a $12.5 million tradename impairment; leverage was 2.4x at March 31, 2025

The filing

CompanyPrestige Consumer Healthcare (PBH)
Form8-K, current report
Filed with the SECMay 8, 2025, 6:04 AM ET
Accession number0001295947-25-000014

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.